effect
result
treatment
active
patient
study
cell
compound
method
group
isolated
Cell
human
drug
level
extract
Compound
protein
Study
receptor
Drug
show
activity
clinical
analysi
response
plasma
concentration
microM
day
disease
therapy
significantly
found
clinic
bind
product
growth
structure
control
vitro
agent
isolate
reaction
showed
structures
strain
resistant
potential
line
data
induce
placebo
rate
metabolite
mice
express
efficacy
RESULTS
expressed
phase
significant
time
potent
trial
enzyme
liver
model
sample
release
gene
chemical
serum
compare
natural
species
week
Blood
pathway
min
conclusion
microg
assay
combined
water
Day
blood
MIC
determined
pressure
sodium
hydrochloride
vivo
Mice
observed
test
muM
site
derived
expression
factor
system
III
mug
elucidated
identify
high
action
viru
identified
membrane
concentrated
derivatives
including
derivative
subject
ring
month
complex
presence
compared
safety
selective
risk
Dose
metabolites
alpha
type
Enzyme
therapeutic
stem
total
Pain
Phase
developed
methyl
chronic
CLINICAL
induced
mass